Stock Earnings

Question 1

What are Immunitybio Inc's key financial statements?

Accepted Answer

According to the latest financial statement (Form-10K), Immunitybio Inc has a total asset of $382, Net loss of $-413

Question 2

What are the key financial ratios for IBRX?

Accepted Answer

Immunitybio Inc's Current ratio is 0.43, has a Net margin is -2,950, sales per share of $0.02.

Question 3

How is Immunitybio Inc's revenue broken down by segment or geography?

Accepted Answer

Immunitybio Inc largest revenue segment is Other, at a revenue of 595,000 in the most earnings release.For geography, United States is the primary market for Immunitybio Inc, at a revenue of 14,214,000.

Question 4

Is Immunitybio Inc profitable?

Accepted Answer

no, according to the latest financial statements, Immunitybio Inc has a net loss of $-413

Question 5

Does Immunitybio Inc have any liabilities?

Accepted Answer

yes, Immunitybio Inc has liability of 872

Question 6

How many outstanding shares for Immunitybio Inc?

Accepted Answer

Immunitybio Inc has a total outstanding shares of 852.9

Breakdown	TTM	12/31/2024	12/31/2023	12/31/2022	12/31/2021	12/31/2020
Revenue	56	14	0	0	0	0
Revenue Growth (YoY)	5,500%	--	--	--	--	-100%
Cost of Revenue	0	0	--	--	--	--
Gross Profit	50	14	--	--	--	--
Selling, General & Admin	152	169	130	103	135	71
Research & Development	187	187	229	245	195	139
Operating Expenses	341	358	361	350	331	210
Other Non Operating Income (Expenses)	47	26	-47	-2	0	0
Pretax Income	-367	-413	-583	-417	-349	-226
Income Tax Expense	0	0	0	0	0	-1
Net Income	-367	-413	-583	-416	-346	-221
Net Income Growth	-39%	-28.99%	40%	20%	56.99%	41%
Shares Outstanding (Diluted)	888.21	697.31	508.63	399.9	389.23	377.07
Shares Change (YoY)	28.99%	37%	27%	3%	3%	3%
EPS (Diluted)	-0.41	-0.59	-1.14	-1.04	-0.89	-0.59
EPS Growth	-53%	-48%	10%	17%	51%	37%
Free Cash Flow	-356	-398	-397	-436	-307	-173
Free Cash Flow Per Share	-0.4	-0.57	-0.78	-1.09	-0.78	-0.45
Gross Margin	89.28%	100%	--	--	--	--
Operating Margin	-508.92%	-2,457.14%	0%	0%	0%	0%
Profit Margin	-655.35%	-2,950%	0%	0%	0%	0%
Free Cash Flow Margin	-635.71%	-2,842.85%	0%	0%	0%	0%
EBITDA	-269	-327	-343	-332	-316	-198
EBITDA Margin	-480.35%	-2,335.71%	0%	0%	0%	0%
D&A For EBITDA	16	17	18	18	14	12
EBIT	-285	-344	-361	-350	-330	-210
EBIT Margin	-508.92%	-2,457.14%	0%	0%	0%	0%
Effective Tax Rate	0%	0%	0%	0%	0%	0.44%

Immunitybio Inc (IBRX) Price

IBRX Stock Price Chart

IBRX Income

Follow-Up Questions